NCT01077154
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Nowotwór
rak piersi
Chorzy
wczesny
Faza badania
III
Sponsor badania
Amgen
Termin
-
Linki
Dane kontaktowe
Gdańsk; Kraków; Olsztyn; Poznań; Rzeszów; Szczecin